Athira Pharma is Conducting Clinical Trials of fosgonimeton

Fosgonimeton is an Investigational Drug

“ATH-1017 is a fast acting novel approach that may have lasting results. — This treatment may lead to rapid and sustained recovery of memory and function.”

Example mechanism of action video for fosgonimenton in Alzheimer's Disease. The same mechanism and therapeutic potential may apply to Parkinson's Disease Dementia or Dementia with Lewy Bodies.